Citation: Ka. Kirou et al., INTERFERON-A INDUCES FASL ON PERIPHERAL-BLOOD MONONUCLEAR-CELLS (PBMCS) AND KILLING OF FAS-SENSITIVE CELLS, Arthritis and rheumatism, 41(9), 1998, pp. 24-24
Citation: Rk. Vakkalanka et al., KINETICS OF CD40 LIGAND (CD40L) MESSENGER-RNA EXPRESSION IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) PATIENTS AND HEALTHY CONTROLS, Arthritis and rheumatism, 41(9), 1998, pp. 1217-1217
Authors:
VAKKALANKA RK
WOO C
KIROU KA
BERGER D
CROW MK
Citation: Rk. Vakkalanka et al., SOLUBLE CD40 LIGAND (SCD40L) IN SERA FROM PATIENTS WITH SLE IS PRESENT AT CONCENTRATIONS THAT CAN MEDIATE B-CELL ACTIVATION, Arthritis and rheumatism, 41(9), 1998, pp. 1218-1218
Authors:
KIROU KA
YAZICI Y
ZUNIGA R
CROW MK
PAGET SA
Citation: Ka. Kirou et al., PULSE GLUCOCORTICOID THERAPY IS NOT ASSOCIATED WITH LOWER BONE-MINERAL DENSITY THAN DAILY ORAL GLUCOCORTICOIDS, Arthritis and rheumatism, 41(9), 1998, pp. 1619-1619
Citation: Ka. Kirou et al., LYMPHOBLASTOID CELL-LINES (LCLS) FROM SLE PATIENTS, DISEASE CONTROLS AND HEALTHY DONORS ARE COMPARABLE IN THEIR SUSCEPTIBILITY TO FAS MEDIATED APOPTOSIS, Arthritis and rheumatism, 40(9), 1997, pp. 1653-1653